XML 77 R20.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Summary of Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2014
Accounting Policies [Abstract] |
Schedule of Medical Payables | The Company’s IBNR reserve for the nine months ended December 31, 2014 was as follows:
Balance, beginning of period |  | $ | 274,000 |
Incurred health care costs: |  |  |  |
Current year |  |  | 2,915,103 |
Prior years |  |  | - |
Total incurred health care costs |  |  | 2,915,103 |
Acquired medical liabilities (see Note 3 ) |  |  | 292,309 |
Claims paid: |  |  |  |
Current year |  |  | (1,929,702) |
Prior years |  |  | (80,661) |
Total claims paid |  |  | (2,010,363) |
Adjustments |  |  | (231,438) |
Balance, end of period |  | $ | 1,239,611 |
Company Accrual Risk Pool Liability | The Company’s accrual for its risk-pool liability for the nine months ended December 31, 2014 was as follows:
Balance, beginning of period |  | $ | 278,561 |
Acquired medical liabilities (see Note 3) |  |  | 128,848 |
Accrual for net deficit from full risk capitation contracts |  |  | 573,203 |
Adjustments |  |  | (414,669) |
Balance, end of period |  | $ | 565,943 |
Fair Value Measurements, Recurring and Nonrecurring | The carrying amounts and fair values of the Company's financial instruments are presented below as of: December 31, 2014
|  | Fair Value Measurements |  |  |  |
|  | Level 1 |  | Level 2 |  | Level 3 |  | Total |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |
Warranty liability |  | $ | - |  | $ | - |  | $ | 2,452,201 |  | $ | 2,452,201 |
Holdback consideration |  |  | - |  |  | - |  |  | 376,236 |  |  | 376,236 |
Conversion feature liability |  |  | - |  |  | - |  |  | 487,630 |  |  | 487,630 |
|  | $ | - |  | $ | - |  | $ | 3,316,067 |  | $ | 3,316,067 |
March 31, 2014
|  | Fair Value Measurements |  |  |  |
|  | Level 1 |  | Level 2 |  | Level 3 |  | Total |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant liability |  | $ | - |  | $ | - |  | $ | 2,354,624 |  | $ | 2,354,624 |
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation | The following summarizes the activity of Level 3 inputs measured on a recurring basis for the three and nine months ended December 31, 2014:
|  | Three months |  | Nine months |
Balance, beginning of period |  | $ | 3,435,086 |  | $ | 2,354,624 |
Warrant liability incurred (Note 7) |  |  | - |  |  | 487,620 |
Change in warrant liability |  |  | (298,279) |  |  | (390,043) |
Holdback consideration |  |  | 239,414 |  |  | 376,236 |
Conversion feature liability incurred (Note 7) |  |  | - |  |  | 578,155 |
Change in conversion feature liability |  |  | (60,154) |  |  | (90,525) |
Balance, end of period |  | $ | 3,316,067 |  | $ | 3,316,067 |
Basic and Diluted Earnings per Share | The following table sets forth the number of shares excluded from the computation of diluted earnings per share, as their inclusion would be anti-dilutive:
|  | Three Months Ended December 31, |  | Nine Months Ended December 31, |
|  | 2014 |  | 2013 |  | 2014 |  | 2013 |
Options |  |  | 3,985,656 |  |  | 4,373,687 |  |  | 4,343,873 |  |  | 5,146,510 |
Warrants |  |  | 851,026 |  |  | 1,428,067 |  |  | 1,381,839 |  |  | 1,562,021 |
9% Convertible Notes |  |  | 102,362 |  |  | 723,723 |  |  | 610,537 |  |  | 513,169 |
|  |  | 4,939,045 |  |  | 6,525,477 |  |  | 6,336,249 |  |  | 7,221,700 |

X
- Definition No authoritative reference available. + References No definition available. + Details
Name: | ameh_ScheduleOfAccrualRiskPoolLiabilityTableTextBlock
Namespace Prefix: | ameh_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19279-110258 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a,b,bb) -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2C -URI http://asc.fasb.org/extlink&oid=36462937&loc=SL7498348-110258 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19279-110258 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 40 -Section 50 -Paragraph 3 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6482485&loc=d3e14764-158437 + Details
Name: | us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration